CaroGen Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CaroGen Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11299
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CaroGen Corp (CaroGen) is an immunotherapy company that offers platform technology development services. The company develops and commercializes virus-like vesicle based therapeutic vaccines. It utilizes its virus-like vesicle platform technology for the development of vaccines for infectious and chronic diseases. CaroGen also develops a portfolio of vaccine candidates targeting hepatitis B, hepatitis C, vesicular stomatitis, influenza, semliki forest, and other viral agents. The company’s virus-like vesicle technologies generated are capable of entering into cells of the vaccinated subject and are propagated to produce the vaccine antigens. It operates through various researchers and academic partners to determine the efficacy of VLV vaccines and to expand its product portfolio. CaroGen is headquartered in Farmington, Connecticut, the US.

CaroGen Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CaroGen Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CaroGen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CaroGen Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CaroGen Raises USD1 Million in Series A Financing 10
CaroGen Raises USD2 Million in Financing 11
CaroGen Raises US$0.15 Million In Pre-Seed Financing 12
Partnerships 13
GeoVax Labs Enters into Agreement with CaroGen 13
CaroGen Enters into Agreement with University of Connecticut 14
CaroGen to Enter into Agreement with GP Healthcare 15
CaroGen Enters into Research Agreement with Yale University 16
Licensing Agreements 17
CaroGen Enters into Licensing Agreement with Yale University 17
CaroGen Corp – Key Competitors 18
CaroGen Corp – Key Employees 19
CaroGen Corp – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
CaroGen Corp, Pharmaceuticals & Healthcare, Key Facts 2
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CaroGen Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CaroGen Corp, Deals By Therapy Area, 2012 to YTD 2018 8
CaroGen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CaroGen Raises USD1 Million in Series A Financing 10
CaroGen Raises USD2 Million in Financing 11
CaroGen Raises US$0.15 Million In Pre-Seed Financing 12
GeoVax Labs Enters into Agreement with CaroGen 13
CaroGen Enters into Agreement with University of Connecticut 14
CaroGen to Enter into Agreement with GP Healthcare 15
CaroGen Enters into Research Agreement with Yale University 16
CaroGen Enters into Licensing Agreement with Yale University 17
CaroGen Corp, Key Competitors 18
CaroGen Corp, Key Employees 19

List of Figures
CaroGen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CaroGen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CaroGen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CaroGen Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AF AB (AF B):電力:M&Aディール及び事業提携情報
    Summary AF AB is an engineering and consulting company. It offers various services such as product development and IT support to several sectors including automotive, telecom, defense and life sciences. The company also provides services such as communications systems management, development of cust …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alnylam Pharmaceuticals Inc (ALNY):製薬・医療:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Lundin Gold Inc:戦略・SWOT・企業財務分析
    Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Idemitsu Kosan Co Ltd (5019):石油・ガス:M&Aディール及び事業提携情報
    Summary Idemitsu Kosan Co Ltd (Idemitsu) is an integrated energy company that explores, produces, refines, and sells oil and gas, lubricants, and petroleum products. The company manufactures agricultural chemicals, agricultural materials, and other chemicals. It explores, develops and extracts coal, …
  • Cocrystal Pharma Inc (COCP):製薬・医療:M&Aディール及び事業提携情報
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Deutsche Apotheker- und Arztebank:企業の戦略・SWOT・財務分析
    Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report Summary Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • TETRA Technologies Inc (TTI):企業の財務・戦略的SWOT分析
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. It offers compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology center and water manageme …
  • Harbour Centre Development Ltd:企業の戦略・SWOT・財務情報
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bharat Heavy Electricals Ltd:企業の戦略・SWOT・財務分析
    Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Michael J Fox Foundation for Parkinson’s Research:製薬・医療:M&Aディール及び事業提携情報
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities. Michael J. Fox offers treatments …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SMA Solar Technology AG (S92)-エネルギー分野:企業M&A・提携分析
    Summary SMA Solar Technology AG (SMA) is a renewable energy company that develops, produces, and distributes photovoltaic (PV) inverters, transformers, choke coils, and monitoring and energy management systems for PV systems. It also offers operation and maintenance services for photovoltaic power p …
  • Mirach Energy Ltd (AWO):企業の財務・戦略的SWOT分析
    Summary Mirach Energy Ltd (Mirach Energy), formerly China Petrotech Holdings Ltd is a diversified company. The company operates through its business such as property and construction and oilfield services. Its oilfield services business offers enhanced oil recovery techniques and consultancy service …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aegis Therapeutics LLC (Aegis Therapeutics) is a biotechnology company that research and develops drug delivery and drug formulation technologies. The company commercializes new drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and bioph …
  • Campanile UK Ltd:企業の戦略・SWOT・財務分析
    Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MicroTransponder Inc:医療機器:M&Aディール及び事業提携情報
    Summary MicroTransponder Inc (MicroTransponder) is a medical device company that develops paired vagus nerve stimulation systems. The company provides paired VNS system which is used in two clinical trials for treating tinnitus and upper limb mobility issues for stroke patients. It also develops SAI …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆